共 42 条
Monitoring post-translational modification of proteins with allosteric ribozymes
被引:46
作者:
Vaish, NK
Dong, F
Andrews, L
Schweppe, RE
Ahn, NG
Blatt, L
Seiwert, SD
机构:
[1] Ribozyme Pharmaceut Inc, Boulder, CO 80301 USA
[2] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA
关键词:
D O I:
10.1038/nbt719
中图分类号:
Q81 [生物工程学(生物技术)];
Q93 [微生物学];
学科分类号:
071005 ;
0836 ;
090102 ;
100705 ;
摘要:
An allosteric hammerhead ribozyme activated specifically by the unphosphorylated form of the protein kinase ERK2 was created through a rational design strategy that relies on molecular recognition of ERK2 to decrease the formation of an alternate, inactive ribozyme conformer. Neither closely related mitogen-activated protein kinases (MAPKs) nor the phosphorylated form of ERK2 induced ribozyme activity. The ribozyme quantitatively detected ERK2 added to mammalian cell lysates and also functioned quantitatively in a multiplexed solution-phase assay. This same strategy was used to construct a second ribozyme selectively activated by the phosphorylated (active) form of ERK2. This approach is generally applicable to the development of ribozymes capable of monitoring post-translational modification of specific proteins.
引用
收藏
页码:810 / 815
页数:6
相关论文